IPHA12:00 AMInnate Pharma to participate in the Jefferies Global Healthcare Conferenceinnate-pharma.com
IPHA12:00 AMInnate Pharma Reports First Quarter 2026 Business Update and Financial Resultsinnate-pharma.com
IPHA12:00 AMInnate Pharma Announces Conference Call and Webcast for Q1 2026 Business Updateinnate-pharma.com
IPHA3:00 PMInnate Pharma to Present MATISSE Phase 2 Interim Results of IPH5201 in Clinical Trials Plenary Session at AACR 2026Interim Data • Phase 2innate-pharma.com
IPHA12:00 AMNumber of Shares and Voting Rights of Innate Pharma as of April 16, 2026innate-pharma.com
IPHA12:00 AMInnate Pharma to Hold Its Annual General Meeting of Shareholders on May 21, 2026innate-pharma.com
IPHA12:00 AMInnate Pharma to Present at the AACR 2026 Oncology Industry Partnering Eventinnate-pharma.com
IPHA4:00 AMInnate Pharma Files Its 2025 Universal Registration Document (Document D’enregistrement Universel) and 2025 Form 20-f Annual Reportinnate-pharma.com
IPHA2:00 AMInnate Pharma Reports Full Year 2025 Financial Results and Business Updateinnate-pharma.com
IPHA2:00 AMInnate Pharma Announces Conference Call and Webcast for Full Year 2025 Financial Resultsinnate-pharma.com